pubmed:abstractText |
?-Sulfone-?-piperidine and ?-tetrahydropyranyl hydroxamates were explored that are potent inhibitors of MMP's-2, -9, and -13 that spare MMP-1, with oral efficacy in inhibiting tumor growth in mice and left-ventricular hypertrophy in rats and in the bovine cartilage degradation ex vivo explant system. ?-Piperidine 19v (SC-78080/SD-2590) was selected for development toward the initial indication of cancer, while ?-piperidine and ?-tetrahydropyranyl hydroxamates 19w (SC-77964) and 9i (SC-77774), respectively, were identified as backup compounds.
|